Download PDF
Aktuelle Ernährungsmedizin 2023; 48(02): 102-116
DOI: 10.1055/a-2035-7632
Übersicht

Klinische Ernährung bei Covid-19 Patienten – Eine systematische Literaturübersicht

Clinical Nutrition in Covid-19 Patients – A Systematic Review
Michaela Spiess
1   Ernährungsmedizin, Regionale Kliniken Holding RKH GmbH, Bietigheim-Bissingen, Germany
,
Arved Weimann
2   Allgemein-, Viszeral- und Onkologische Chirurgie , Klinikum St. Georg Leipzig, Leipzig, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

EinleitungAktuell fehlt die Evidenz zur klinischen Ernährung bei Covid-19. Ziel der Arbeit: Systematischer Überblick über die klinische Ernährung bei Covid-19.

Material und MethodeEine systematische Literatursuche: 2 Meta-Analysen, 12 systematische Reviews und Meta-Analysen, 9 prospektive randomisierte kontrollierte Studien, 3 prospektive Observationsstudien, 7 retrospektive Studien, 25 narrative Reviews.

Ergebnisse a) Adipöse Patienten haben ein erhöhtes Risiko auf einen schweren Krankheitsverlauf, b) es gibt einen Zusammenhang zwischen Adipositas und erhöhtem Sterberisiko, c) die Covid-19 Mortalität steigt ab einem BMI>27 kg/m², in allen BMI- Klassen um 1,6% pro 1 kg/m² bei Gewichtszunahme, bei starker Adipositas (> 40–45 BMI) um das 1,5 bis 2-fache und pro 5 kg/m², d) das Risiko für einen schweren Covid-19 Verlauf steigt ebenso bei erhöhtem viszeralen Fettgewebeanteil, Gesamtkörperfettmasse und Oberbauchumfang, e) die Sterblichkeitsrate kann bei mangelernährten Covid-19 Patienten 10-mal höher sein, f) das Serumalbumin liefert Hinweise auf einen schlechten Krankheitsverlauf, g) eine enterale Omega-3-Fettsäuren-Zufuhr könnte die Nierenfunktion stabilisieren und das Outcome verbessern, h) Lebensmittel mit niedrigen glykämischen Index sollten bevorzugt werden, i) ein Vitamin D Mangel ist zu vermeiden, eine tägliche Vitamin D und Zink Supplementierung kann von Vorteil sein, j) einmalig hochdosiertes Vitamin D und enterales Vitamin C bewirkt keinen Nutzen, jedoch könnte das Thromboserisiko reduziert und mit Zink die Antikörperreaktion verstärkt werden, k) eine ernährungsmedizinische Intervention reduziert die Sterblichkeit.

Schlussfolgerung Screening und Erfassung des Ernährungszustands sind bei Covid-19 Patienten von Bedeutung. Insgesamt liegen unzureichend klinische Ergebnisse zur spezifischen Ernährungstherapie vor.

Abstract

Introduction There is currently a lack of evidence on clinical nutrition in Covid-19. Aim of the work: Systematic overview of clinical nutrition in Covid-19.

Material and methods A systematic literature search: 2 meta-analyses, 12 systematic reviews and meta-analyses, 9 prospective randomized controlled trials, 3 prospective observational studies, 7 retrospective studies, 25 narrative reviews.

Results a) Obese patients have an increased risk of a severe course of the disease, b) there is a connection between obesity and an increased risk of death, c) Covid-19 mortality increases from a BMI>27 kg/m², in all BMI classes 1,6% per 1 kg/m² in the event of weight gain, in the case of severe obesity (> 40–45 BMI) by a factor of 1,5 to 2 and per 5 kg/m², d) the risk of a severe course of Covid-19 increases also with increased visceral fat tissue percentage, total body fat mass and upper abdominal circumference, e) the mortality rate can be 10 times higher in malnourished Covid-19 patients, f) serum albumin provides evidence of a poor course of the disease, g) enteral omega-3 fatty acid intake could stabilize kidney function and improve the outcome, h) foods with a low glycemic index should be preferred, i) vitamin D deficiency should be avoided, daily vitamin D and zinc supplementation can be beneficial, j) one-time high dose vitamin D and enteral vitamin C provide no benefit, but the risk of thrombosis could be reduced and the antibody response enhanced with zinc, k) nutritional intervention reduces mortality.

Conclusion Screening and assessment of nutritional status are important in Covid-19 patients. Overall, there are insufficient clinical results on specific nutritional therapy.

Schlüsselwörter

Covid-19 - Ernährungszustand - Klinische Ernährung - Körperzusammensetzung - Ernährungstherapie

Key words

Covid-19 - nutritional status - clinical nutrition - body composition - nutritional therapy


Publication History

Received: 19 July 2022

Accepted: 19 January 2023

Article published online:
08 May 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literature

  • 1 Calder P, Carr A, Gombart A. et al. Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 2020; 12: 7-14 DOI: 10.3390/nu12041181.
    CrossrefPubMedGoogle Scholar
  • 2 Matricardi P, Dal Negro R, Nisini R. et al. The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures. Paediatr Allergy and Immunol 2020; 31: 454-470 DOI: 10.1111/pai.13271.
    CrossrefPubMedGoogle Scholar
  • 3 Opal S, Girard T, Ely E. The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis 2005; 41: S504-S512 DOI: 10.1086/432007.
    CrossrefPubMedGoogle Scholar
  • 4 Richardson S, Hirsch J, Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with covid-19 in the New York city area. JAMA 2020; 323: 2052-2059 DOI: 10.1001/jama.2020.6775.
    CrossrefPubMedGoogle Scholar
  • 5 Wang C, Liu Z, Chen Z. The establishment of reference sequence for SARS-CoV-2 and variation analysis. J Med Virol 2020; 92: 667-674 DOI: 10.1002/jmv.25762.
    CrossrefPubMedGoogle Scholar
  • 6 Abate S, Chekole Y, Estifanos M. et al. Prevalence and outcomes of malnutrition among hospitalized COVID-19 patients: A systematic review and meta-analysis. Clin Nutr ESPEN 2021; 174-183 DOI: 10.1016/j.clnesp.2021.03.002.
    CrossrefPubMedGoogle Scholar
  • 7 Soetedjo N, Iryaningrum M, Damara F. et al. Prognostic properties of hypoalbuminemia in COVID19 patients: A systematic review and diagnostic meta-analysis. Clin Nutr ESPEN 2021; 45: 120-126 DOI: 10.1016/j.clnesp.2021.07.003.
    CrossrefPubMedGoogle Scholar
  • 8 Huang H, Bukhari K, Chiung-Hui Peng C. et al. The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis. Diabetes Obes Metab 2021; 23: 1701-1709 DOI: 10.1111/dom.14382.
    CrossrefPubMedGoogle Scholar
  • 9 Malik P, Patel U, Patel K. et al. Obesity a predictor of outcomes of COVID-19 hospitalized patients-A systematic review and meta-analysis. J Med Virol 2021; 93: 1188-1193 DOI: 10.1002/jmv.26555.
    CrossrefPubMedGoogle Scholar
  • 10 Poly T, Islam M, Yang H. et al. Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021; 620044 DOI: 10.3389/fmed.2021.620044.
    CrossrefPubMedGoogle Scholar
  • 11 Mahamat-Saleh Y, Fiolet T, Rebeaud M. et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021; 11: e052777 DOI: 10.1136/bmjopen-2021-052777.
    CrossrefPubMedGoogle Scholar
  • 12 Huang Y, Guo H, Zhou Y. et al. The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes. Diabetes Res Clin Pract 2020; 169: 108448 DOI: 10.1016/j.diabres.2020.108448.
    CrossrefPubMedGoogle Scholar
  • 13 Pranata R, Lim MA, Huang I. et al. Visceral adiposity, subcutaneous adiposity, and severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. Clin Nutr ESPEN 2021; 43: 163-168 DOI: 10.1016/j.clnesp.2021.04.001.
    CrossrefPubMedGoogle Scholar
  • 14 Földi M, Farkas N, Kiss S. et al. Visceral Adiposity Elevates the Risk of Critical Condition in COVID-19: A Systematic Review and Meta-Analysis. Obesity (Silver Spring) 2021; 29: 521-528 DOI: 10.1002/oby.2309.
    CrossrefPubMedGoogle Scholar
  • 15 Petersen A, Bressem K, Albrecht J. et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism 2020; 110: 154317 DOI: 10.1016/j.metabol.2020.154317.
    CrossrefPubMedGoogle Scholar
  • 16 Rashedi S, Keykhaei M, Pazoki M. et al. Clinical significance of prognostic nutrition index in hospitalized patients with COVID19: Results from single-center experience with systematic review and meta-analysis. Nutr Clin Pract 2021; 36: 970-983 DOI: 10.1002/ncp.10750.
    CrossrefPubMedGoogle Scholar
  • 17 Leal Martinez F, Abarca-Bernal L, García-Pérez A. et al. Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial. Int J Environ Res Public Health 2022; 19: 1172 DOI: 10.3390/ijerph19031172.
    CrossrefPubMedGoogle Scholar
  • 18 Pimentel R, Silva A, Santana A. et al. Effect of immunonutrition on serum levels of C-reactive protein and lymphocytes in patients with COVID-19: a randomized, controlled, double-blind clinical trial. Nutr Hosp 2022; 39: 20-26 DOI: 10.20960/nh.03847.
    CrossrefPubMedGoogle Scholar
  • 19 Doaei S, Gholami S, Rastgoo S. et al. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial. J Transl Med 2021; 19: 128 DOI: 10.1186/s12967-021-02795-5.
    CrossrefPubMedGoogle Scholar
  • 20 Ao G, Li J, Yuan Y. et al. Intravenous vitamin C use and risk of severity and mortality in COVID-19: A systematic review and meta-analysis. Nutr Clin Pract 2022; 37: 274-281 DOI: 10.1002/ncp.10832.
    CrossrefPubMedGoogle Scholar
  • 21 Rawat D, Roy A, Maitra S. et al. Vitamin C and COVID-19 treatment: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr 2021; 15: 102324 DOI: 10.1016/j.dsx.2021.102324.
    CrossrefPubMedGoogle Scholar
  • 22 JamaliMoghadamSiahkali S, Zarezade B, Koolaji S. et al. Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res 2021; 26: 20 DOI: 10.5492/wjccm.. v6.i1.85
    CrossrefPubMedGoogle Scholar
  • 23 Sulaiman K, Aljuhani O, Saleh K. et al. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Sci Rep 2021; 11: 17648 DOI: 10.1038/s41598-021-96703-y.
    CrossrefPubMedGoogle Scholar
  • 24 Xing Y, Zhao B, Yin L. Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding. J Pharm Biomed Anal 2020; 196: 113927 DOI: 10.1038/s41598-021-96703-y.
    CrossrefPubMedGoogle Scholar
  • 25 Thomas S, Patel T, Bittel B. et al. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw Open 2021; 4: e210369 DOI: 10.1001/jamanetworkopen.2021.0369.
    CrossrefPubMedGoogle Scholar
  • 26 Bassatne A, Basbous M, Chakhtoura M. et al. The link between COVID-19 and Vitamin D (VIVID): A systematic review and metaanalysis. Metabolism 2021; 154753 DOI: 10.1016/j.metabol.2021.154753.
    CrossrefPubMedGoogle Scholar
  • 27 Sabico S, Enani M, Sheshah E. et al. Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients 2021; 13: 2170 DOI: 10.3390/nu13072170.
    CrossrefPubMedGoogle Scholar
  • 28 AlSafar H, Grant W, Hijazi R. et al. COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents. Nutrients 2021; 13: 1714 DOI: 10.3390/nu13051714.
    CrossrefPubMedGoogle Scholar
  • 29 Saponaro F, Franzini M, Okoye C. et al. Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? Front. Immunol 2022; 12: 745713 DOI: 10.3389/fimmu.2021.745713.
    CrossrefPubMedGoogle Scholar
  • 30 Fernandes A, Murai I, Reis B. et al. Effect of a single high dose of vitamin D3 on cytokines, chemokines, and growth factor in patients with moderate to severe COVID-19. Am J Clin Nutr 2022; 115: 790-798 DOI: 10.1093/ajcn/nqab426.
    CrossrefPubMedGoogle Scholar
  • 31 Tan C, Ho L, Kalimuddin S. et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition 2020; 79-80 111017 DOI: 10.1016/j.nut.2020.111017.
    CrossrefPubMedGoogle Scholar
  • 32 Borsche L, Glauner B, von Mendel J. COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients 2021; 13: 3596 DOI: 10.3390/nu13103596.
    CrossrefPubMedGoogle Scholar
  • 33 Chen J, Mei K, Xie L. et al. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs. Nutr J 2021; 20: 89 DOI: 10.1186/s12937-021-00744-y.
    CrossrefPubMedGoogle Scholar
  • 34 Quek A, Ooi D, Teng O. et al. Zinc and vitamin C intake increases spike and neutralising antibody production following SARS-CoV-2 infection. Clin Transl Med 2022; 12: e731 DOI: 10.1002/ctm2.731.
    CrossrefPubMedGoogle Scholar
  • 35 Hackler J, Heller R, Sun Q. et al. Relation of Serum Copper Status to Survival in COVID-19. Nutrients 2021; 13: 1898 DOI: 10.3390/nu13061898.
    CrossrefPubMedGoogle Scholar
  • 36 Heller R, Sun Q, Hackler J. et al. Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 2021; 38: 101764 DOI: 10.1016/j.redox.2020.101764.
    CrossrefPubMedGoogle Scholar
  • 37 Ben Abdallah S, Mhalla Y, Trabelsi I. et al. Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial. Clin Infect Dis 2023; 13: 185-191 DOI: 10.1093/cic/ciac807.
    CrossrefPubMedGoogle Scholar
  • 38 Fan L, Zhu X, Zheng Y. et al. Magnesium treatment on methylation changes of transmembrane serine protease 2 (TMPRSS2). Nutrition 2021; 89: 111340 DOI: 10.1016/j.nut.2021.111340.
    CrossrefPubMedGoogle Scholar
  • 39 Rees C, Rostad C, Mantus G. et al. Altered amino acid profile in patients with SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2021; 118: e2101708118 DOI: 10.1073/pnas.2101708118.
    CrossrefPubMedGoogle Scholar
  • 40 Singer P, Blaser A, Berger M. et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr 2019; 38: 48-79 DOI: 10.1016/j.clnu.2018.08.037.
    CrossrefPubMedGoogle Scholar
  • 41 Elke G, Hartl W, Kreymann K. et al. Klinische Ernährung in der Intensivmedizin. Clin Nutr ESPEN 2019; 3: 220-275 DOI: 10.1016/j.clnesp.2019.05.002.
    CrossrefPubMedGoogle Scholar
  • 42 Kluge S, Janssens U, Welte T. et al. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19. Med Klin Intensivmed Notfmed 2020; 115: 175-177 DOI: 10.1007/s00063-020-00674-3.
    CrossrefPubMedGoogle Scholar
  • 43 Barazzoni R, Bischoff S, Krznaric Z et al. ESPEN-Expertenerklärungen und praktischer Leitfaden für das Ernährungsmanagement von Patienten mit SARS-CoV-2-Infektion. Aktuel Ernahrungsmed 2020; 45: 182–192. DOI:10.1055/a-1179-9594
    PubMed